Evidence map›Paper›PMID 25346373›Full record

Trial reportClinical oral investigations2015

Taurolidine as an effective and biocompatible additive for plaque-removing techniques on implant surfaces.

Gordon John, Frank Schwarz, Jürgen Becker

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Clinical oral investigations, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gordon JohnDepartment of Oral Surgery, Heinrich Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany, Gordon.John@med.uni-duesseldorf.de.
Frank Schwarz
Jürgen Becker
Heinrich Heine University Düsseldorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of the present study was the evaluation of the effectiveness and efficiency of two plaque-removing techniques, plastic curettes (PC) and glycine powder airflow (GLY) in combination with taurolidine (T), chlorhexidine (CHX), or pure water (PW) as additives and compared to groups without previous treatment (NT). MATERIALS AND

methodsPlaque was collected on titanium samples for 48 h in six subjects. Specimens were worn in a special splint in the upper jaw and randomly assigned to test and control groups. After biofilm removal procedures, clean implant surface (CIS) on the samples and treatment time were taken as parameters.

resultsMean CIS was determined in the following descending order: T-GLY > CHX-GLY > NT-GLY > T-PC > PW-GLY > PW-PC > CHX-PC > NT-PC. Mean treatment time was determined in the following ascending order: T-GLY < CHX-GLY < PW-GLY < NT-GLY < T-PC < CHX-PC < PW-PC < NT-PC.

conclusionsWithin the limits of this study, it can be concluded that T showed the highest CIS in the GLY and PC groups. T-GLY showed significantly more CIS than all other GLY groups. The T-PC group showed significantly more CIS than all other PC groups. The treatment times of the T groups were significantly lower than their corresponding PC or GLY groups. CLINICAL RELEVANCE: The results of the current study indicate that taurolidine seems to enhance effectiveness of plaque-removing procedures with plastic curettes and glycine powder airflow. Also, the efficiency of both treatment procedures seems to be increased.

Indexed as

Dental ImplantsAdultAir Abrasion, DentalAnti-Infective Agents, LocalBiocompatible MaterialsBiofilmsChlorhexidineDental PlaqueFemaleHumansMaleTaurineThiadiazinesTitaniumAnti-Infective Agents, LocalBiocompatible MaterialsChlorhexidineDental ImplantsTaurinetaurolidineThiadiazinesTitanium

Identifiers

PMID25346373
OpenAlexW1974533348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.